Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Affiliations

• ¹ Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Norway.
• ² Dana-Farber Cancer Institute, Boston, MA.
• ³ Lille University Hospital, Lille, France.
• ⁴ Hospital Universitario La Princesa and Hospital Quironsalud, Madrid.
• ⁵ Alfred Health-Monash University, Melbourne, Australia.
• ⁶ Jagiellonian University Medical College, Krakow, Poland.
• ⁷ National Hospital Organization Okayama Medical Center, Okayama, Japan.
• ⁸ Hôpital Necker-Enfants Malades, Paris, France.
• ⁹ Seoul St. Mary Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South).
• ¹⁰ Sanofi CMO, Chilly-Mazarin, France.
• ¹¹ Sanofi Global Oncology, Cambridge, MA.
• ¹² Sanofi R-D, Vitry-sur-Seine, France.
• ¹³ Sanofi R-D, Cambridge, MA.
• ¹⁴ Sanofi RD, Cambridge, MA.
• ¹⁵ University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino.